Determinants of skeletal fragility

被引：140
作者：
Bouxsein, ML
机构：
[1] Harvard Univ, Sch Med, Dept Orthopaed Surg, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2005年 / 19卷 / 06期
关键词：
biomechanics; skeletal fragility; bone mineral density; bone remodeling; microarchitecture; microdamage; mineralization; collagen; bone shape;
D O I：
10.1016/j.berh.2005.07.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Strategies to reduce fracture risk must be based on a sound understanding of the mechanisms that underline the increased incidence of fractures with age and with certain diseases. There is evidence that in addition to bone minerals density, other factors influence bone strength. The chapter reviews the biomechanical aspects of age-related fractures, including the interacting roles of traumatic loading and bone strength, and the factors that determine a bones resistances to fracture. Also discussed are the mechanisms by which anti-catabolic and anabolic therapies for osteoporosis may affect bone strength. Finally, several current and future methodologies for improving assessment of bone strength in patients are evaluated.
引用
收藏
页码：897 / 911
页数：15
相关论文
共 90 条
[1]  
Aaron JE, 2000, BONE, V27, P277, DOI 10.1016/S8756-3282(00)00328-8
[2]   Bone loss and bone size after menopause [J].
Ahlborg, HG ;
Johnell, O ;
Turner, CH ;
Rannevik, G ;
Karlsson, MK .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) :327-334
[3]  
[Anonymous], BON HLTH OST REP SUR
[4]   AGE-RELATED-CHANGES IN FEMALE FEMORAL-NECK GEOMETRY - IMPLICATIONS FOR BONE STRENGTH [J].
BECK, TJ ;
RUFF, CB ;
BISSESSUR, K ;
HEANEY ;
RAISZ ;
REEVE .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 :S41-S46
[5]  
BELL G. H., 1967, CALCIFIED TISSUE RES, V1, P75, DOI 10.1007/BF02008077
[6]   Methodological considerations in measurement of bone mineral content [J].
Boivin, G ;
Meunier, PJ .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (Suppl 5) :S22-S27
[7]   Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women [J].
Boivin, G ;
Lips, P ;
Ott, SM ;
Harper, KD ;
Sarkar, S ;
Pinette, KV ;
Meunier, PJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) :4199-4205
[8]   Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women [J].
Boivin, GY ;
Chavassieux, PM ;
Santora, AC ;
Yates, J ;
Meunier, PJ .
BONE, 2000, 27 (05) :687-694
[9]   A MURINE SKELETAL ADAPTATION THAT SIGNIFICANTLY INCREASES CORTICAL BONE MECHANICAL-PROPERTIES - IMPLICATIONS FOR HUMAN SKELETAL FRAGILITY [J].
BONADIO, J ;
JEPSEN, KJ ;
MANSOURA, MK ;
JAENISCH, R ;
KUHN, JL ;
GOLDSTEIN, SA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1697-1705
[10]   Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography [J].
Borah, B ;
Dufresne, TE ;
Chmielewski, PA ;
Johnson, TD ;
Chines, A ;
Manhart, MD .
BONE, 2004, 34 (04) :736-746
123456789